01/29/2026
https://www.facebook.com/share/p/1DN3LHUyqh/?mibextid=wwXIfr
Postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a drug for overweight and obesity treatment, according to a new study led by Mayo Clinic.
The findings could lead to research for more personalized weight management for postmenopausal women, who are at higher risk for obesity-related cardiovascular disease.
Read more: https://mayocl.in/3LFYmEO